We investigated whether insulin resistance is associated with impaired cardiac fatty acid metabolism in maintenance hemodialysis patients without coronary artery disease. We studied 55 nondiabetic (63711 years old) and 51 diabetic (61710 years old) hemodialysis patients with normal coronary arteries, using single-photon emission computed tomography (SPECT) with an iodinated fatty acid analogue, iodine-123-b-methyl iodophenyl-pentadecanoic acid ( 123 I-BMIPP), to evaluate cardiac fatty acid metabolism. SPECT imaging was graded regionally from 0 (normal) to 4 (absence of tracer) to calculate a summed score for 17 left ventricular segments. Insulin resistance was determined using the homeostasis model assessment index of insulin resistance (HOMA-IR). HOMA-IR correlated with summed BMIPP score in nondiabetic and diabetic patients. Stepwise multiple regression analysis showed that HOMA-IR was independently associated with BMIPP summed score in nondiabetic (b ¼ 0.774, t ¼ 9.218, P ¼ 0.0001) and diabetic patients (b ¼ 0.792, t ¼ 9.079, P ¼ 0.0001). Left ventricular ejection fraction was lower in nondiabetic subjects with BMIPP summed score of at least 6 plus HOMA-IR of at least 4 than in others with lower values for both assessments (53.1713.8%, n ¼ 20 vs 67.779.1%, n ¼ 23, P ¼ 0.0002); this was also true in diabetic subjects (50.9715.2%, n ¼ 24 vs 71.0713.6%, n ¼ 11, P ¼ 0.0007). Association between insulin resistance and impaired cardiac fatty acid metabolism may contribute to left ventricular dysfunction in patients with maintenance hemodialysis without coronary diseases.
We investigated whether insulin resistance is associated with impaired cardiac fatty acid metabolism in maintenance hemodialysis patients without coronary artery disease. We studied 55 nondiabetic (63711 years old) and 51 diabetic (61710 years old) hemodialysis patients with normal coronary arteries, using single-photon emission computed tomography (SPECT) with an iodinated fatty acid analogue, iodine-123-b-methyl iodophenyl-pentadecanoic acid ( 123 I-BMIPP), to evaluate cardiac fatty acid metabolism. SPECT imaging was graded regionally from 0 (normal) to 4 (absence of tracer) to calculate a summed score for 17 left ventricular segments. Insulin resistance was determined using the homeostasis model assessment index of insulin resistance (HOMA-IR). HOMA-IR correlated with summed BMIPP score in nondiabetic and diabetic patients. Stepwise multiple regression analysis showed that HOMA-IR was independently associated with BMIPP summed score in nondiabetic (b ¼ 0.774, t ¼ 9.218, P ¼ 0.0001) and diabetic patients (b ¼ 0.792, t ¼ 9.079, P ¼ 0.0001). Left ventricular ejection fraction was lower in nondiabetic subjects with BMIPP summed score of at least 6 plus HOMA-IR of at least 4 than in others with lower values for both assessments (53.1713.8%, n ¼ 20 vs 67.779.1%, n ¼ 23, P ¼ 0.0002); this was also true in diabetic subjects (50.9715.2%, n ¼ 24 vs 71.0713.6%, n ¼ 11, P ¼ 0.0007). Association between insulin resistance and impaired cardiac fatty acid metabolism may contribute to left ventricular dysfunction in patients with maintenance hemodialysis without coronary diseases. Congestive heart failure is a strongly predictive, independent risk factor for mortality in patients with end-stage renal disease (ESRD) undergoing maintenance hemodialysis. [1] [2] [3] According to the US Renal Data System, both coronary artery disease and congestive heart failure independently predicted mortality in a cohort of 3399 hemodialysis patients. 2 In the Hemodialysis (HEMO) study, 4 a randomized multicenter investigation of 1846 maintenance hemodialysis patients, congestive heart failure and coronary artery disease, respectively, were diagnosed in 40 and 39% of the patients. Previous studies 5, 6 including one by us 7 have shown that maintenance hemodialysis patients have high prevalence of significant coronary artery stenosis. Whereas coronary artery disease undoubtedly is a major or cardinal cause of congestive heart failure, left ventricular dysfunction is often recognized in maintenance hemodialysis patients with no apparent epicardial coronary artery disease. Other factors such as arteriovenous shunt, anemia, 8 hypertension, 9 or chronic fluid overload 10 may contribute to heart failure, but few studies have investigated possible abnormal cardiac fatty acid metabolism as a cause of ventricular dysfunction in ESRD patients without coronary disease.
Over 70% of energy expenditure required by the normal myocardium under aerobic conditions is derived from metabolism of free fatty acids. 11 Under hypoxic or ischemic conditions, fatty acid metabolism is suppressed and replaced by glucose metabolism, which consumes less oxygen but is less efficient than fatty acid metabolism in terms of adenosine triphosphate (ATP) synthesis. 12 Iodine-123-b-methyl iodophenyl-pentadecanoic acid ( 123 I-BMIPP) is a branched free fatty acid analogue characterized by resistance to b-oxidation in mitochondria. Single-photon emission computed tomography (SPECT) using 123 I-BMIPP as a tracer is considered to reflect fatty acid metabolism in the heart. Because cardiac BMIPP uptake is related to left ventricular wall motion 13, 14 and myocardial accumulation of BMIPP correlates well with intracellular ATP content, [15] [16] [17] [18] [19] which has also strong association with left ventricular wall motion, 20, 21 clinical or laboratory factors that decrease BMIPP SPECT imaging intensity may contribute to left ventricular dysfunction in hemodialysis patients who do not have coronary artery disease. In the present study, we particularly focused on whether insulin resistance, which is widely prevalent among ESRD patients [22] [23] [24] and is likely to cause microcirculatory disturbance via endothelial dysfunction, is associated with impaired cardiac fatty acid metabolism in maintenance hemodialysis patients without coronary artery disease.
RESULTS

Factors influencing left ventricular function
In nondiabetic hemodialysis patients, left ventricular ejection fraction (LVEF), a parameter indicating systolic left ventricular function, correlated inversely with BMIPP summed score (Figure 1a) , homeostasis model assessment index of insulin resistance (HOMA-IR) (r ¼ À0.600, P ¼ 0.0001), plasma immunoreactive insulin (IRI) concentration (r ¼ À0.553, P ¼ 0.0001), fasting plasma glucose concentration (r ¼ À0.292, P ¼ 0.030), and serum high-sensitive C-reactive protein (hs-CRP) concentration (r ¼ À0.480, P ¼ 0.0002), but did not correlate with other clinical or laboratory factors listed in Table 1 . Among the factors correlating with LVEF, BMIPP summed score was significantly associated with LVEF by multiple regression analysis (Table 2 ) and also by multiple regression analysis using a stepwise method (b ¼ À0.571, t ¼ À5.070, P ¼ 0.0001). BMIPP summed score did not correlate with left ventricular end-diastolic dimension (Figure 1a) . In diabetic hemodialysis patients, LVEF correlated positively with serum high-density lipoprotein (HDL)-cholesterol concentration (r ¼ 0.362, P ¼ 0.009) and inversely with BMIPP summed score (Figure 1b) , HOMA-IR (r ¼ À0.606, P ¼ 0.0001), and plasma IRI concentration (r ¼ À0.594, P ¼ 0.0001); no correlation was found with fasting plasma glucose concentration or other clinical or laboratory factors listed in Table 1 . Among the factors correlated with LVEF for the subgroup with diabetes, BMIPP summed score was highly and significantly associated with LVEF by multiple regression analysis (Table 2) , as well as multiple regression analysis using a stepwise method (b ¼ À0.723, t ¼ À7.326, P ¼ 0.0001). BMIPP summed score tended to correlate with left ventricular end-diastolic dimension (Figure 1b) . 
Cardiac fatty acid metabolism and insulin resistance
Mean BMIPP summed score did not differ between nondiabetic and diabetic patients (7.579.6 (n ¼ 55) vs 9.97 8.7 (n ¼ 51)). Mean fasting plasma glucose concentration was higher in diabetic patients than in nondiabetic patients (Table 3) , as well as multiple regression analysis using a stepwise method (b ¼ 0.792, t ¼ 9.079, P ¼ 0.0001). In our previous study, a BMIPP summed score of 6 was the cutoff value for detecting coronary artery disease in maintenance hemodialysis patients. 7 Mean LVEF was lower in the subgroup with BMIPP summed score of 6 or more and HOMA-IR of at least 4.0 than in the subgroup with BMIPP summed score not exceeding 5 and HOMA-IR below 4.0 in both nondiabetic and diabetic patients (Figure 3 ). In addition, the group with left ventricular systolic dysfunction (LVEFo45%) showed higher BMIPP summed scores (nondiabetic, 23.17 14.8 (n ¼ 8) vs 3.472.8 (n ¼ 27), P ¼ 0.0001; diabetic, 19.7710.9 (n ¼ 11) vs 5.473.3 (n ¼ 24), P ¼ 0.0001) and higher HOMA-IR (nondiabetic, 7.072.0 (n ¼ 8) vs 3.871.4 (n ¼ 27), P ¼ 0.0001; diabetic, 7.572.1 (n ¼ 11) vs 4.071.6 (n ¼ 24), P ¼ 0.0001) than the group with normal systolic left ventricular function (LVEFX65%). Typical images by BMIPP SPECT of nondiabetic and diabetic hemodialysis patients who had high BMIPP summed scores, high HOMA-IR, and low LVEF are presented in Figure 4 .
Systemic inflammation
BMIPP summed score correlated positively with serum hs-CRP concentration in nondiabetic and diabetic patients (Figures 2a and b) . HOMA-IR correlated positively with serum hs-CRP concentration in nondiabetic (r ¼ 0.649, P ¼ 0.0001, n ¼ 55) and diabetic patients (r ¼ 0.603, P ¼ 0.0001, 
DISCUSSION
In the present study, BMIPP summed score was negatively associated with LVEF, whereas HOMA-IR, a parameter indicating insulin resistance, was positively associated with BMIPP summed score in both nondiabetic and diabetic hemodialysis patients with no evidence of epicardial coronary artery disease. Further, a group of patients with higher BMIPP summed score and HOMA-IR had lower LVEF than a group of patients with lower BMIPP summed score and HOMA-IR. Hemodialysis patients with systolic left ventricular dysfunction (LVEFo45%) had higher mean BMIPP summed scores and mean HOMA-IR than those with normal systolic left ventricular function (LVEFX65%). When SPECT shows reduced uptake of BMIPP (i.e. high BMIPP summed score), cardiac fatty acid metabolism is considered to be impaired and replaced by glucose metabolism, which requires less oxygen consumption but produces less ATP.
11,12
Efficiency of myocardial ATP synthesis is expected to be further reduced when glucose utilization is inhibited by the presence of insulin resistance. A combination of impaired cardiac fatty acid metabolism with insulin resistance may be involved in left ventricular dysfunction via reduction of myocardial ATP content in maintenance hemodialysis patients without coronary artery disease.
Previous investigations of metabolism and kinetics of BMIPP in myocardial cells have shown that BMIPP SPECT imaging indicates mainly accumulation of acetyl BMIPP in the lipid pool of cardiomyocytes, whereas myocardial ATP content plays a key role in the accumulation of acetyl BMIPP in the lipid pool; decrease in myocardial ATP content leads to reduction of BMIPP uptake in SPECT images. [15] [16] [17] [18] [19] Therefore, the higher values of the BMIPP summed score obtained by BMIPP SPECT are thought to reflect not only impaired cardiac fatty acid metabolism but also the reduction of myocardial ATP content, which is likely to be related to left ventricular dysfunction. 18, 19 ESRD patients are known to exhibit glucose intolerance, 22 a reflection of insulin resistance. 23, 24 Tissue insensitivity to insulin is the primary cause of insulin resistance in ESRD. 25 Insulin resistance may be linked with vascular endothelial dysfunction, [26] [27] [28] which may be largely a consequence of acquired defects of nitric oxide synthesis and intracellular signaling. 28, 29 In endothelial smooth muscle cells, nitric oxide is important for vasodilation and is degraded by reactive oxygen species. Depleted nitric oxide and increased reactive oxygen species induced by insulin resistance are thought to contribute together to endothelial damage and impairment of vasodilation. Endothelial damage and impaired vasorelaxation caused by insulin resistance appear to have particularly significant effects on small arterioles, where failure of vasodilation may result in direct tissue ischemia. Jaap et al. 30 reported an association between insulin sensitivity and microvascular function in nondiabetic subjects with fasting hyperglycemia. Serne et al. 31 reported that microvascular function as assessed by laser Doppler flowmetry is associated with insulin sensitivity even in normal subjects. In addition, a strong correlation between glucoseclamp-derived indices of insulin resistance and coronary vascular function assessed by Doppler blood flow recordings has been demonstrated in subjects with unobstructed coronary arteries. 32 Endothelial dysfunction linked with insulin resistance is believed to take part in the microcirculatory disturbance in the heart [33] [34] [35] [36] and compromise myocardial ATP synthesis in ESRD patients.
Insulin resistance has been linked to high-normal serum CRP concentrations. [37] [38] [39] In the present study, serum hs-CRP concentration correlated positively with the HOMA-IR as well as the BMIPP summed score in both nondiabetic and diabetic patients. In multiple regression analysis, HOMA-IR was strongly associated with serum hs-CRP in both groups. Insulin resistance is thought to cause endothelial inflammation mainly via nitric oxide depletion and increased reactive oxygen species. Subclinical elevation of serum CRP in hemodialysis patients with normal coronary arteries may reflect microvascular inflammation induced by insulin resistance, which is likely to lead to microcirculatory disturbance and impaired fatty acid metabolism in the heart. In the present study, we did not use the 'gold standard' for assessment of insulin resistance, the glucose clamp method. 40 HOMA relies on the product of fasting plasma glucose and fasting plasma insulin, and is concerned essentially with hepatic insulin sensitivity; 41, 42 in contrast, the euglycemic, hyperinsulinemic clamp technique measures insulinmediated glucose disposal in peripheral tissues. 42 Use of HOMA, therefore, would represent a limitation of this study. On the other hand, many previous studies have shown that HOMA-IR has a close correlation with clamp-measured insulin resistance in patients with or without diabetes mellitus, [43] [44] [45] including subjects with chronic renal failure. 46 Although the predictive value of HOMA-IR for insulin resistance has been questioned among Japanese elderly patients more than 70 years old with poorly controlled type II diabetes, 47 this point would not affect the reliability of HOMA-IR in the present study because the diabetic patients more than 70 years old had not been so poorly controlled; their serum hemoglobin A1c values ranged from 4.8 to 6.5%. Although HOMA-IR is considered a reliable method for clinical assessment of insulin resistance in maintenance hemodialysis patients of the present study, use of HOMA-IR as a parameter indicating the extent of insulin resistance could be a bias in interpreting the results of this study.
Insulin resistance determined by HOMA-IR was associated with impaired cardiac fatty acid metabolism demonstrated by BMIPP SPECT imaging in maintenance hemodialysis patients with normal coronary arteries, irrespective of the presence or absence of diabetes mellitus. Although fatty acid and glucose are normally major energy substrates in the myocardium, glucose oxidation is thought to be decreased and fatty acid oxidation enhanced in myocardial mitochondria of patients with insulin resistance, increasing the oxygen requirement per ATP molecule produced. However, as ESRD patients have generally microcirculatory disturbance in the heart, the oxygen supply to the myocardial cells does not seem to be sufficient for increased fatty acid oxidation, particularly in hemodialysis patients with cardiac microcirculatory disturbance. As a result, cardiac fatty acid metabolism as well as glucose metabolism in myocardial cells would be impaired, and myocardial ATP synthesis is expected to be reduced in hemodialysis patients with insulin resistance. Because myocardial ATP content deeply affects left ventricular wall motion, a combination of insulin resistance with impaired cardiac fatty acid metabolism may aggravate left ventricular dysfunction. Understanding the relationship between insulin resistance and impaired cardiac fatty acid metabolism is important for establishment of congestive heart failure in hemodialysis patients without coronary artery disease.
MATERIALS AND METHODS Patients
We enrolled 55 nondiabetic and 51 diabetic hemodialysis patients; patients in both these groups were undergoing maintenance hemodialysis at Toujinkai Hospital. Characteristics of study subjects are presented in Table 1 . In all diabetic patients, type II diabetes mellitus had been treated before initiation of hemodialysis, but they had received neither insulin nor oral antidiabetic drugs for at least 6 months preceding the start of this study. Their mean serum hemoglobin A1c value was 5.971.2% (4.0-10.0%); serum hemoglobin A1c values ranged from 4.8 to 6.5% in elderly diabetic patients more than 70 years old. All nondiabetic and diabetic patients had been demonstrated to have normal coronary arteries by coronary angiography performed at the Department of Interventional Cardiology of the Second Kyoto Red Cross Hospital within 30 days before the blood sampling, as well as myocardial scintigraphy and echocardiography. Quantitative coronary angiographic analysis was performed using a validated automated edge-detection program (CCIP-310/W; Cathex, Tokyo, Japan); maximal luminal stenosis in coronary arteries was less than 25% in all subjects. Patients diagnosed with acute or old myocardial infarction, idiopathic hypertrophic, or dilated cardiomyopathy, or congestive heart failure (New York Heart Association grades III-IV) were excluded. In addition, patients receiving any medication likely to affect left ventricular function, such as angiotensin I-converting enzyme inhibitors, type-1 angiotensin II receptor blockers, a1-blockers, b-blockers, ab-blockers, a2-agonists, or short-acting Ca blockers, were also excluded from this study. Hemodialysis was performed three times weekly using a dialysate containing Na þ (140 mEq/l), K . Histories of cigarette smoking and alcohol consumption were ascertained by questionnaire. A smoking habit was defined as 10 or more cigarettes per week. Alcohol consumption was defined as alcohol intake of 20 g or more per week. The Ethics Committee for Human Research of Toujinkai Hospital approved this study (Committee Protocol number 6), and all patients provided informed consent prior to participation.
Radionuclide imaging
All patients underwent resting 123 I-BMIPP myocardial scintigraphy after fasting for over 6 h on a midweek nondialysis day within 30 days after coronary angiography. A 111-MBq dose of 123 I-BMIPP (Nihon Medi-Physics, Tokyo, Japan) was injected intravenously with patients seated. Fifteen minutes after the injection, data for SPECT were acquired from a 64 Â 64 matrix in 32 directions, at 61 intervals from the 451 right anterior oblique position to the 451 left posterior oblique position, for 30 s per direction, using a commercially available gamma camera (Starcam 4000i; GE Medical Systems, Waukesha, WI, USA) equipped with a low-energy, all-purpose collimator. Energy discrimination was centered at 159 keV with a 20% window. Data were entered into an online nuclear medicine data processor (IMC12C4-5, GE Medical Systems). Tomographic images then were constructed with short-axis, horizontal-axis, and verticalaxis sections. Raw imaging data were reconstructed with ramp filter, and high-frequency noise was decreased with the Butterworth-filtered (order, 8; cutoff frequency ¼ 0.82 cycle/cm) back-projection technique. The threshold level was 20%, and attenuation correction was not used. Ventricular SPECT images were divided into 17 segments for semiquantitative analysis according to the standard myocardial segmentation for tomographic imaging of the heart established by the American Heart Association. Radioactivity of each segment was graded visually and assigned a score from 0 to 4 (0 ¼ normal uptake, 1 ¼ mildly reduced, 2 ¼ moderately reduced, 3 ¼ severely reduced, 4 ¼ no uptake). The sum of scores by BMIPP SPECT for 17 myocardial segments was designated the BMIPP summed score. The same experienced technician performed scintigraphic procedures in all cases, and the same two investigators, who had no clinical information about the patients, interpreted the images in all cases.
Echocardiography measurements
Echocardiography was performed for each patient using a single ultrasonographic recorder (UF-8800, Fukuda Denshi, Tokyo, Japan) on a midweek nondialysis day within 30 days after coronary angiography. Left ventricular dimensions and LVEF were quantified by the biplanar Simpson's rule, and left ventricular mass was measured as recommended by the American Society of Echocardiography. 48 Left ventricular mass was normalized to body surface area, and is reported as the left ventricular mass index.
Biochemical and hematological determinations
Blood samples (5 ml) were obtained in the morning after an overnight fast, on a midweek dialysis day within 30 days after coronary angiography, after the patient had been in the supine position for at least 10 min. Hemoglobin (and hemoglobin A1c for diabetic patients), plasma intact parathyroid hormone concentration, and serum concentrations of albumin, total cholesterol, HDLcholesterol, triglycerides, and hs-CRP were determined. Total cholesterol and triglycerides were measured enzymatically. HDLcholesterol was measured after precipitating apolipoprotein B-containing lipoproteins with dextran sulfate and magnesium chloride. Plasma intact parathyroid hormone was measured using a chemiluminescence assay (Chemiluminescence intact PTH 100T kit; Nichols Institute Diagnostics, San Juan Capistrano, CA, USA). Serum hs-CRP concentration was measured using a high-sensitivity assay kit (N-Assay LA CRP-S, D-type; Nittobo, Tokyo, Japan); the intra-and inter-assay coefficients of variation for this assay ranged from 0.6 to 1.6% and from 0.7 to 2.1%, respectively.
Assessment of insulin resistance
We used fasting plasma glucose and fasting plasma insulin concentrations to calculate HOMA-IR according to the formula HOMA-IR ¼ (baseline glucose concentration (mmol/l) Â baseline insulin concentration (mU/ml)/22.5). Blood was collected on the same day as the blood collection for other biochemical and hematological parameters. Glucose was measured by a glucose oxidase method, and insulin was measured by a chemiluminescence enzyme immunoassay method (LS-insulin, Eiken Chemical, Tokyo, Japan) as IRI: the intra-and inter-assay coefficients of variation for this assay ranged from 1.3 to 3.9% and from 1.6 to 6.8%, respectively, and the coefficient of correlation between the chemiluminescence enzyme immunoassay method and the radioimmunometric assay (Insulin RIA-BEAD II, Dinabot, Tokyo, Japan) was 0.992 (the regression equation: y ¼ 0.96x þ 0.68, n ¼ 208).
Statistical analysis
Values are expressed as the mean7s.d. Differences in continuous variables between groups were evaluated by Wilcoxon's rank-sum test. Associations of LVEF or BMIPP summed score with other clinical and laboratory factors were evaluated using multiple regression analyses. All statistical tests were two-sided, with a value for P below 0.05 defining significance. A Statistical Analysis Software package (SPSS for Windows, versions 9.0J and 11.0J; Chicago, IL, USA) system was used.
